Parent or LAR provides signed informed consent and patient provides assent (when applicable).
Confirmed diagnosis of HAE.
You may not be if
Confirmed diagnosis of HAE with nC1-INH or acquired angioedema
Patient weighs \<9.5 kg
Patient participated in the KVD900-303 trial and withdrew prior to trial completion per the protocol or trial closure
Any clinically significant medical condition or medical history that, in the opinion of the Treating Physician, would interfere with the patient's safety.
Known hypersensitivity to sebetralstat or its excipients.
Patient with a medical history or known to have severe hepatic impairment (Child Pugh C).
Patients who require sustained use of strong cytochrome P450 3A4 inhibitors or inducers.
